Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Medicaid Preferred Drug List

You may register to receive E-mail notification, when a new Preferred Drug List is posted to the Web site, by completing the form for Preferred Drug List E-Mail Notification Request. 

Instructions for Provider PDL Review Requests

The Department of Healthcare and Family Services (HFS), Bureau of Professional and Ancillary Services (BPAS) occasionally, receives requests from clinicians in the provider community for individual drug reviews. To ensure requests for reviews are fair, balanced, and relevant to the Medicaid Preferred Drug List (PDL), BPAS has established procedures for handling these requests. After BPAS receives the request for a drug review, BPAS pharmacy staff establish the appropriateness of the request.  The review takes place over a three-month period, beginning from the date the drug review is requested. Reviews are evaluated both clinically and financially. A recommendation may be presented to the D&T Advisory Board at the earliest opportunity.

E-mail requests to:  HFS.UniversalPDL@Illinois.gov​​

Preferred Drug List

Archived Preferred Drug Lists